Key facts
- Notable investors include Bolboreta Innova Group.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Connectoma
- ·The full record, as it builds
Funding rounds
No funding rounds for Connectoma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Connectoma
Provider of AI-guided neuromodulation and precision brain mapping designed for achieving rapid clinical remission in patients with treatment-resistant mental health conditions. The company offers an AI-driven neurotechnology platform that integrates fMRI imaging and personalized neuronavigation to deliver millimeter-accurate brain stimulation, enabling clients to offer intensive protocols for depression, anxiety, and OCD in a fraction of the time required by traditional treatments.
- Sector
- Healthcare
- HQ
- Madrid, Spain
- Founded
- 2024
- Employees
- 7
- Website
- connectoma.com/
- Ownership
- Privately Held (backing)
Connectoma doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Connectoma shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Connectoma in its N-PORT filings yet. We sweep new filings monthly.